TestLab ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Bankruptcy risk for industry  3.3% 3.3% 3.3% 3.3% 3.3%  
Bankruptcy risk  19.3% 14.0% 30.0% 32.8% 23.1%  
Credit score (0-100)  6 14 1 0 4  
Credit rating  B BB C C B  
Credit limit (kDKK)  -0.0 0.0 -0.0 -0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Gross profit  -355 -229 17.4 300 2,213  
EBITDA  -614 -1,440 -1,258 -521 2,210  
EBIT  -624 -1,451 -1,307 -610 1,922  
Pre-tax profit (PTP)  -597.4 -1,452.3 -1,317.5 -625.4 1,926.1  
Net earnings  -597.4 -1,452.3 -1,317.5 -625.4 1,926.1  
Pre-tax profit without non-rec. items  -597 -1,452 -1,317 -625 1,926  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Tangible assets total  34.8 24.2 16.1 9.4 0.0  
Shareholders equity total  5.4 403 -140 -765 1,161  
Interest-bearing liabilities  0.0 0.0 83.4 641 0.0  
Balance sheet total (assets)  295 1,021 872 371 1,161  

Net Debt  -102 -828 -266 634 -1,157  
 
See the entire balance sheet

Volume 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -355 -229 17.4 300 2,213  
Gross profit growth  0.0% 35.5% 0.0% 1,621.8% 637.9%  
Employees  2 3 3 2 0  
Employee growth %  0.0% 50.0% 0.0% -33.3% -100.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  295 1,021 872 371 1,161  
Balance sheet change%  176.1% 245.7% -14.6% -57.5% 213.3%  
Added value  -613.9 -1,440.2 -1,258.0 -560.6 2,210.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  14 -21 313 -178 -586  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -5.0 -5.0 -5.0 -5.0 1.0  

Profitability 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  175.5% 632.8% -7,507.0% -203.4% 86.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -79.9% -220.3% -128.6% -56.8% 167.7%  
ROI %  -108.5% -574.7% -448.6% -168.3% 213.7%  
ROE %  -1,062.9% -711.0% -206.6% -100.6% 251.6%  

Solidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Equity ratio %  1.8% 39.5% -13.8% -67.4% 100.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  16.6% 57.5% 21.2% -121.8% -52.3%  
Gearing %  0.0% 0.0% -59.6% -83.8% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.4% 0.0% 24.3% 4.3% 0.0%  

Liquidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Quick Ratio  0.9 1.9 0.9 0.1 0.0  
Current Ratio  0.9 1.9 0.9 0.1 0.0  
Cash and cash equivalent  101.6 828.2 349.6 7.1 1,156.5  

Capital use efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -29.3 475.2 -45.6 -1,041.3 1,160.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Net sales / employee  0 0 0 0 0  
Added value / employee  -307 -480 -419 -280 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -307 -480 -419 -260 0  
EBIT / employee  -312 -484 -436 -305 0  
Net earnings / employee  -299 -484 -439 -313 0